References
- Gates GA, Green JD. Jr. Intermittent pressure therapy of intractable meniere's disease using the meniett device: a preliminary report. Laryngoscope. 2002;112(8 Pt 1):1489–1493.
- Sajjadi H, Paparella MM. Meniere's disease. Lancet. 2008;372(9636):406–414.
- Peterson WM, Isaacson JE. Current management of Ménière's disease in an only hearing ear. Otol Neurotol. 2007;28(5):696–699.
- Shojaku H, Watanabe Y, Mineta H, et al. Long-term effects of the meniett device in japanese patients with meniere's disease and delayed endolymphatic hydrops reported by the Middle ear pressure treatment research group of Japan. Acta Otolaryngol. 2011;131(3):277–283.
- Feldmann H. [Tympanic membrane massage, origin and decline of a promising therapeutic concept]. Laryngorhinootologie. 1996;75(8):491–498. In German
- Watanabe Y, Shojaku H, Junicho M, et al. Intermittent pressure therapy of intractable meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report. Acta Otolaryngol. 2011;131(11):1178–1186.
- Shojaku H, Aoki M, Takakura H, et al. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable meniere’s disease and delayed endolymphatic hydrops: a prospective study. Acta Otolaryngol. 2015 Sep 14; 1-8. doi: https://doi.org/10.1080/00016489.2021.1942979.
- Olusesi A, Oyeniran O. Persistence of Non-Vertigo symptoms in meniere disease during Remission - A preliminary report. Otolaryngol Pol. 2020;74(4):31–36.
- Mattox DE, Reichert M. Meniett device for Ménière's disease: use and compliance at 3 to 5 years. Otol Neurotol. 2008;29(1):29–32.
- Dornhoffer JL, King D. The effect of the meniett device in patients with Ménière's disease: long-term results. Otol Neurotol. 2008;29(6):868–874.
- Watanabe I. Ménière's disease with special emphasis on epidemiology, diagnosis and prognosis. ORL J Otorhinolaryngol Relat Spec. 1980;42(1-2):20–45.
- Komatsuzaki A, Harada Y, Hozawa J, et al. Delayed endolymphatic hydrops. Equilib. Res. 1987;47:245–273.
- Mizukoshi K, Watanabe Y, Shojaku H, et al. Preliminary guidelines for reporting treatment results in Menière's disease conducted by the Committee of the Japanese Society for Equilibrium Research, 1993. Acta Otolaryngol Suppl. 1995;519:211–215.
- Gates GA, Verrall A, Green JD, Jr, et al. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2006;132(12):1311–1316.
- Densert B, Sass K. Control of symptoms in patients with meniere's disease using Middle ear pressure applications: two years follow-up. Acta Otolaryngol. 2001;121(5):616–621.
- Pearson BW, Brackmann DE. Committee on hearing and equilibrium guidelines for reporting treatment results in meniere's disease. Otolaryngol Head Neck Surg. 1985;93(5):579–581.
- Nishihara S, Gyo K, Yanagihara N. Transmission of change in the atmospheric pressure of the external ear to the perilymph. Am J Otol. 1992;13(4):364–368.
- Barbara M, Monini S, Chiappini I, et al. Meniett therapy may avoid vestibular neurectomy in disabling meniere's disease. Acta Otolaryngol. 2007;127(11):1136–1141.
- Huang W, Liu F, Gao B, et al. Clinical long-term effects of meniett pulse generator for meniere's disease. Acta Otolaryngol. 2009;129(8):819–825.
- Rajan GP, Din S, Atlas MD. Long-term effects of the meniett device in meniere's disease: the Western australian experience. J Laryngol Otol. 2005;119(5):391–395.